Status:
COMPLETED
Electro Flo 5000 and Vest Therapy
Lead Sponsor:
Stanford University
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
12+ years
Phase:
PHASE4
Brief Summary
It is the goal of the proposed study to compare the efficacy, as assessed primarily by sputum weight, of these two different devices (the Electroflo 500 and VEST therapy) for airway clearance (AC) in ...
Eligibility Criteria
Inclusion
- Diagnosis of CF established by standard criteria (sweat chloride \> 60 mmol/L and/or two alleles affected by gene mutations know to be associated with CF).
- Age older than 12 years.
- Known to consistently produce sputum.
- Currently on a home therapeutic regimen that includes some form of AC performed at least 2 times daily.
- FVC and FEV1 \> 40%-predicted, and with stable lung function (no greater than a 10% variation in lung function parameters over the preceding 3 months).
Exclusion
- Hospitalization for CF pulmonary complications in the 2 months preceding enrollment.
- Hemoptysis \> 60 cc in a single episode in the 4 weeks preceding enrollment.
- Chronic chest pain.
- Participation in another interventional clinical trial in the previous 30 days. -
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT02277626
Start Date
April 1 2012
End Date
April 1 2013
Last Update
January 12 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.